Market Tracker

10/21 6:05pm ET

Actavis PLC (NYSE:ACT)

232.13
Data as of Oct 21
 +5.46 / +2.41%
Today’s Change
143.71
Today|||52-Week Range
249.94
+38.17%
Year-to-Date

Today’s Trading

Previous close226.67
Today’s open228.79
Day’s range227.06 - 233.50
Volume1,691,090
Average volume (3 months)2,441,969
Market cap$59.9B
Dividend yield--
Data as of 4:03pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+39.96%
Earnings growth (next 5 years)+18.86%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.14

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.93+2.24%
AGNAllergan Inc+6.91+3.85%
LLYEli Lilly and Co+1.58+2.50%
CELGCelgene Corp+2.97+3.23%
Data as of 4:14pm ET, 10/21/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$3.10
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts